logo
Bat VC launches $100 million fund to back US and Indian AI startups

Bat VC launches $100 million fund to back US and Indian AI startups

A VC firm that plans to back buzzy early-stage AI startups across the US and India has just launched a second fund with a target close of $100 million.
New York-headquartered Bat VC, founded by a trio of Indian tech veterans from Yahoo, Twitter India, and Intuit, is currently raising its second fund. It aims to back early-stage startups predominantly in the AI, fintech, and enterprise sectors, cutting checks of $3 million to $5 million.
The VC firm has made a strategic decision to back startups across India and the US — two markets it sees teeming with potential for startups to bilaterally scale, particularly as the US and China remain in a trade war.
Bat VC's managing director and general partner, Aditya Mishra, said Fund 2 serves as a follow-on pot for the firm's first fund, a $8.2 million vehicle that is on track for a 29% internal rate of return and has two exits so far.
"We look at early-stage from the lens of whether startups have achieved product market fit," Mishra told Business Insider. "You could have a very strong team, but you may be lacking the sales and the go-to-market skill set, or you may not have a good team technically, but you are pretty good at selling whatever you have."
Bat VC is still fundraising for the first close of its second fund and is in talks with over 10 limited partners, including institutional LPs, family offices, fund of funds, and high-net-worth individuals, Mishra told BI.
A global trade shift is spurring more VC interest in India
While US startups rake in the most VC funding globally, India is experiencing a startup boom. As of January, the country reported having over 159,000 recognized startups and credited them with creating about 1.7 million direct jobs since 2016, according to India's Ministry of Commerce and Industry.
The country is increasingly a hotbed for Big Tech operations. Apple produced $22 billion worth of iPhones in India in the 12 months preceding March as the tech giant pivots its manufacturing base away from China, while Meta is in talks to set up its first data center in India.
There's also a growing trend of reverse brain drain. Encouraged by India's growth and market size, Indian expats who moved to the US to work in Big Tech are leaving hefty paychecks behind to return home and build consumer and fintech startups.
Although the trade war between the US and China is facing a 90-day reprieve, the uncertainty could make India a more attractive alternative choice for investors seeking tech talent and opportunities to scale their startups in software-savvy markets.
All of this has created fertile conditions for tech innovation in India, particularly in AI, said Ravi Metta, Bat VC's US head and general partner.
"Because of the AI resurgence, companies across the world are pushing more work into India," he said. "What's going to happen because of that is that more and more people in India will start becoming entrepreneurs, building these global companies using AI."
Supply chain constraints could also lead to more Big Tech companies setting up in India, and leaning on AI to carry out work in areas like logistics, Mishra told BI, adding that this could lead to more robotics and manufacturing innovation in the country.
Manish Maheshwari, Bat VC's India head and general partner, told BI that many US founders may want to access India, particularly for enterprise software, and compared it to the US-Israel corridor, but with the potential to be "10 times bigger."
As the US seeks more economic ties to alternative manufacturing hubs in Asia, India's bilateral relationship with the US is "going to be an order of magnitude higher," he added. "So that is where India also has an advantage."

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Why Plug Power Stock Popped Today
Why Plug Power Stock Popped Today

Yahoo

time2 hours ago

  • Yahoo

Why Plug Power Stock Popped Today

Plug Power wants authority to issue more shares. Either that, or it wants to conduct a reverse stock split. If shareholders let it do the first thing, it might be able to avoid doing the second thing. 10 stocks we like better than Plug Power › Shares of Plug Power (NASDAQ: PLUG), the maker of fuel cell systems -- and now also of the hydrogen to fuel them -- shot 13% higher through 1:11 p.m. ET Friday, as investors received encouragement that the company might be able to avoid a devastating (to morale) reverse stock split. Our story begins one week ago, when Plug Power sent shareholders a preliminary proxy statement advising of the matters that will be raised at its July 3 annual general meeting: "Approval of an amendment to the Company's charter to increase the number of authorized shares of the Company's common stock from 1,500,000,000 shares to 3,000,000,000 shares;" and "Approval of ... a reverse stock split ... at a ratio of not less than 1-for-5 and not more than 1-for-200." Unable to earn a profit selling fuel cells or hydrogen, Plug Power has to continually create and sell new shares to keep itself solvent. But as its share count approaches 1.1 billion, the company will soon need to authorize more shares to keep this ball rolling. Either that, or it must shrink its share count through a reverse split -- and then resume growing the share count again. As a business model, this all leaves much to be desired. I certainly wouldn't invest in Plug Power myself. But as points out today, Plug is pleading with investors to approve at least one of the above options so that it can remain in business. As a consolation prize, Plug is also assuring investors that if they raise the ceiling on shares outstanding, it can avoid the reverse-split option. Investors seem encouraged by this assurance today. That's why they're bidding Plug stock up. Before you buy stock in Plug Power, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Plug Power wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $674,395!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $858,011!* Now, it's worth noting Stock Advisor's total average return is 997% — a market-crushing outperformance compared to 172% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of June 2, 2025 Rich Smith has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. Why Plug Power Stock Popped Today was originally published by The Motley Fool

Is Hims & Hers Health a Smart Buy Right Now?
Is Hims & Hers Health a Smart Buy Right Now?

Yahoo

time3 hours ago

  • Yahoo

Is Hims & Hers Health a Smart Buy Right Now?

Hims & Hers is the newest darling disrupting the telemedicine space. While shares have jumped 157% over the last year, Wall Street analysts don't seem overly bullish on the stock. Despite impressive results in the business, Hims & Hers has a high short interest -- making a short-squeeze a possibility. 10 stocks we like better than Hims & Hers Health › When it comes to stocks that continue to beat the market, my guess is that your mind goes straight to companies leading the charge in artificial intelligence (AI). Sure, stocks such as Palantir Technologies or CoreWeave remain red-hot in a strong technology sector. But smart investors understand that there are myriad opportunities beyond the usual suspects in tech. One company that has emerged as a new favorite among investors is telemedicine business Hims & Hers Health (NYSE: HIMS). With shares up 157% over the last 12 months as of market close June 4, Hims & Hers Health looks like the next monster growth stock at the intersection of healthcare and technology. Let's assess the state of Hims & Hers' business and then take a look at what Wall Street thinks. Is buying shares of this telemedicine darling a good idea right now? Read on to find out. Hims & Hers is a telemedicine platform that offers patients access to a variety of medications, including for skin care, anxiety, sexual health, and even weight loss. At the core of the company's business model is a subscription platform. At the end of the first quarter, Hims & Hers boasted 2.4 million subscribers, which represented an increase of 38% year over year. This translated into revenue of $586 million for the quarter, up by a jaw-dropping 111% year over year. By keeping its business primarily online, Hims & Hers can benefit in a couple of ways. First, subscription revenue is recurring and therefore carries high gross margins. Second, by keeping its user base using its offerings, the company has the flexibility to spend less on marketing and invest in other areas, such as technology or research and development, in an effort to bolster customer acquisition strategies. Per management's vision, Hims & Hers is doubling down on investments in AI to get a better sense of its customer data. This could be a savvy move, as it may help the company unlock new expansion opportunities. While the ideas above paint a picture of a fast-growing, disruptive new solution in the healthcare space, Wall Street doesn't seem totally sold on Hims & Hers just yet. Over the last month, a number of equity research analysts, including Piper Sandler, Citigroup, Bank of America, and Morgan Stanley, have each maintained ratings of neutral, sell, underperform, or equal-weight. Another way of looking at this is that among some of the largest banks on Wall Street, none seem to have a compelling buy rating on Hims & Hers stock. In addition, the average price estimate among analysts for Hims & Hers stock is roughly $48, implying 12% downside from trading levels as of June 4. Given Wall Street's somewhat bearish sentiment, what could be fueling the stock's seemingly unstoppable rally? I think the company's high short interest could be the cause of the rise in its stock. Per the chart above, roughly 35% of Hims & Hers float is sold short. Investors who short a stock are betting its price will fall. Short interest of 10% or more is considered unusually high. Not only is Hims & Hers' short interest much higher than the usual benchmarks, it's also rising. A high short interest can fuel volatility and even a rise in a stock's price if investors who are shorting a stock need to buy shares in the company to return the borrowed shares and close out their position. This is known as short covering, and it often leads to pronounced increases in a stock for a fleeting period of time, adding to volatility. You might be more familiar with these dynamics as a short squeeze. Despite notable subscriber growth and expanding markets, Hims & Hers stock exhibits too much volatility for my liking, and with that, comes a high degree of uncertainty. At first glance, I can understand what makes Hims & Hers look like an appealing investment. Telemedicine represents a compelling opportunity at the intersection of healthcare and technology, and Hims & Hers has certainly proven that it can consistently acquire users and monetize them. Moreover, the prospects that AI presents in the healthcare space more broadly shouldn't be discounted -- further validating the vision management has for Hims & Hers' long-term growth. Nevertheless, I struggle to look past the meme stock type of behavior exhibited here. While some investors have certainly made money owning this stock, I am suspicious if their profits were sparked by the right reasons. Said differently, I view Hims & Hers as more of a swing trading stock (timing is everything) as opposed to a sound long-term opportunity at this time. For these reasons, I would pass on Hims & Hers at the moment. While I'm intrigued by the company's potential, I think shares have run up considerably and would not be surprised to see some contraction in the share price sooner than later. Before you buy stock in Hims & Hers Health, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Hims & Hers Health wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $669,517!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $868,615!* Now, it's worth noting Stock Advisor's total average return is 792% — a market-crushing outperformance compared to 171% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of June 2, 2025 Bank of America is an advertising partner of Motley Fool Money. Citigroup is an advertising partner of Motley Fool Money. Adam Spatacco has positions in Palantir Technologies. The Motley Fool has positions in and recommends Bank of America, CrowdStrike, Hims & Hers Health, and Palantir Technologies. The Motley Fool has a disclosure policy. Is Hims & Hers Health a Smart Buy Right Now? was originally published by The Motley Fool Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Scammers targeting NYC parking meters: How to protect your money
Scammers targeting NYC parking meters: How to protect your money

Yahoo

time3 hours ago

  • Yahoo

Scammers targeting NYC parking meters: How to protect your money

The Brief Scammers are placing fraudulent QR code stickers on NYC parking meters, leading drivers to phishing websites to steal payment information. The Department of Transportation acted swiftly by notifying users, inspecting meters, and working with Microsoft to remove the phishing site. Cybersecurity expert Robert Siciliano advises using official apps for parking payments and monitoring credit card statements, while reporting any suspicious QR codes. NEW YORK - Drivers beware! Scammers are targeting New York City parking meters by placing fraudulent QR code stickers on machines, directing drivers to third-party websites to steal payment information. What we know The Department of Transportation warns that scanning these QR codes leads to a phishing site where users are asked for payment details, which are then stolen by scammers. At least one fake sticker was found on a meter, prompting immediate action from the agency, including notifications to users, inspections of all meters, and collaboration with Microsoft to remove the phishing site. What they're saying Cybersecurity expert Robert Siciliano advises vigilance, noting that lone QR codes are often fraudulent. "A lone QR code that is plastered on is usually going to be fraud," he said. "Most municipalities and cities know at this point that there are three to five different apps that consumers might use to log in to pay for their parking, and as long as you have that app on your phone, generally you should be good." He also emphasizes monitoring credit card statements for unauthorized charges. "The problem with this particular crime is if you are not paying attention to your credit card statements in real time and pay the bill, you are responsible for that fraud," he said. What you can do The official way to pay for metered parking in the city is through the ParkNYC app or by inserting a credit card directly into the meter. Reporting any suspicious QR codes is crucial. The Source This article uses information from the New York City DOT and cybersecurity expert Robert Siciliano.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store